Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer
2 Visningar
• 07/14/23
0
0
Bädda in
administrator
Prenumeranter
Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.
For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna